Axa
CC icon

Axa’s Chemours CC Stock Holding History

Axa’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,634
Closed -$248K – 246
2025
Q2 		$248K Buy
+21,634
New +$244K ﹤0.01% 1066
2023
Q4 		– Sell
-20,400
Closed -$572K – 1075
2023
Q3 		$572K Sell
20,400
-9,600
-32% -$330K ﹤0.01% 919
2023
Q2 		$1.11M Buy
30,000
+3,800
+15% +$116K ﹤0.01% 826
2023
Q1 		$784K Sell
26,200
-2,977
-10% -$98.1K ﹤0.01% 913
2022
Q4 		$893K Hold
29,177
– – ﹤0.01% 904
2022
Q3 		$719K Buy
29,177
+8,000
+38% +$264K ﹤0.01% 912
2022
Q2 		$678K Sell
21,177
-61,700
-74% -$2.27M ﹤0.01% 930
2022
Q1 		$2.61M Sell
82,877
-49,823
-38% -$1.56M 0.01% 785
2021
Q4 		$4.45M Buy
132,700
+99,000
+294% +$3.08M 0.01% 687
2021
Q3 		$979K Sell
33,700
-42,800
-56% -$1.39M ﹤0.01% 968
2021
Q2 		$2.66M Sell
76,500
-40,700
-35% -$1.35M 0.01% 836
2021
Q1 		$3.27M Sell
117,200
-3,800
-3% -$101K 0.01% 771
2020
Q4 		$3M Hold
121,000
– – 0.01% 784
2020
Q3 		$2.53M Buy
+121,000
New +$2.33M 0.01% 773
2018
Q3 		– Sell
-153,492
Closed -$6.81M – 1337
2018
Q2 		$6.81M Sell
153,492
-85,521
-36% -$4.25M 0.03% 567
2018
Q1 		$11.6M Sell
239,013
-219,300
-48% -$11M 0.05% 401
2017
Q4 		$22.9M Buy
458,313
+389,313
+564% +$20.4M 0.09% 264
2017
Q3 		$3.49M Buy
+69,000
New +$3.26M 0.02% 718
2015
Q4 		– Sell
-11,560
Closed -$75K – 1407
2015
Q3 		$75K Buy
+11,560
New +$121K ﹤0.01% 1328

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Axa's CC Position: Q3 2025 in Review

Axa sold out of Chemours (CC) in Q3 2025, closing a stake of 21,634 shares — an estimated $248K sold.

Axa first reported a position in CC in Q3 2015 and held it in 19 quarters. The position peaked at $22.9M in Q4 2017. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Axa reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
  • Axa sold 21,634 Chemours shares in Q3 2025, an estimated $248K.
  • Axa first reported a position in Chemours in Q3 2015 and held it in 19 quarters.
  • Axa's Chemours position peaked at $22.9M in Q4 2017.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.